Patents Represented by Attorney Elizabeth Arwine
  • Patent number: 6628751
    Abstract: An apparatus including but not limited to a charge-coupled device(CCD)-array sensor positioning mechanism, the positioning mechanism structured to position a CCD-array sensor to capture a first target area; and the CCD-array sensor positioning mechanism further structured to position the CCD-array sensor to capture a second target area proximate to the first target area, the first and second target areas spatially related such that a first radiographic image recorded at the first target area may be combined with a second radiographic image recorded at the second target area to form a composite radiographic image substantially analogous to a single radiographic image of an aggregate target area covered by the first and second target areas.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: September 30, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Steven L. Eikenberg
  • Patent number: 6620412
    Abstract: In this application are described vaccinia monoclonal antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of vaccinia virus infections in vitro and in vivo.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: September 16, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Jay W. Hooper, Alan L. Schmaljohn, Connie S. Schmaljohn
  • Patent number: 6613556
    Abstract: The present invention provides a method for replicating virus to high titer in cultured mammalian cells by infecting the mammalian cells with the high titer virus strain to obtain infected cells, specifically, attenuated dengue virus strains of serotype 1, 2, 3, and 4. The resulting replicated virus is suitable for use in vaccines and vaccination methods which are also provided by the invention.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: September 2, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Kenneth H. Eckels, Joseph R. Putnak, Bruce L. Innis
  • Patent number: 6610045
    Abstract: An orthogonal arterial catheter preferably includes a hub and a cannula. The hub preferably protects the cannula from potential kinking and shearing forces because the cannula upon exiting a patient's body enters the hub. The hub preferably provides a passageway through which the hose travels to a connector piece. The connector piece preferably attaches the device to a fluid line such as an arterial line transducer. In addition, the hub preferably includes a port that provides a channel through which a guide wire or a needle may gain access to the cannula. The hub also may include appendages extending from it to suture to the patient.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: August 26, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Saturnino Chavez, Steven C. Walker, John M. Shepherd
  • Patent number: 6573244
    Abstract: The compounds of the invention are generally described by the formula: B1Z*2B3Z*4X*5Q6F7X8X9X10X11  (1), B1X2X3X4X5Q6F7X8X9X10X11  (2), or B1X2B3X4Z5Q6F7Z*8X9X10X11  (3) and the salts, esters, amides, and acyl forms thereof. Each position represented by a letter indicates a single amino acid residue: B is a basic or polar/large amino acid or a modified form thereof; X is a small or hydrophobic amino acid or a modified form thereof; X* is a small or polar/large amino acid or a modified form thereof; Z is a polar/large or hydrophobic amino acid or a modified form thereof; Z* is Proline or a polar/large or hydrophobic amino acid or a modified form thereof. As described below, one or more of the peptide linkages between the amino acid residues may be replaced by a peptide linkage mimic. These compounds may be used as molecular building blocks to create compounds that are optimized for inhibiting the protease activity of Botulinum B and tetanus toxins.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: June 3, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Richard K. Gordon, Debbie R. Moorad, Bhupendra P. Doctor, Gregory E. Garcia
  • Patent number: 6565054
    Abstract: The device is for attaching a syringe or other type of dispenser to a container containing pharmaceutical. The device preferably includes a rubber band and a syringe holder. The syringe holder preferably includes an attachment lip, a bracket, and a clamp. The attachment lip and bracket preferably frame the rubber band, which is used to hold the attachment lip against the container. The clamp preferably is used to engage and hold the syringe.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: May 20, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Kathryn A. Weesner, Steven C. Walker, John M. Shepherd
  • Patent number: 6562376
    Abstract: In this application is described a poxvirus naked DNA vaccine which protects animals against poxvirus challenge comprising IMV and EEV nucleic acids from poxvirus. Methods of use of the vaccine and its advantages are described.
    Type: Grant
    Filed: March 7, 2001
    Date of Patent: May 13, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Jay W. Hooper, Alan L. Schmaljohn, Connie S. Schmaljohn
  • Patent number: 6555334
    Abstract: A method is described of viewing a single tissue sample with a light microscope and an electron microscope. A tissue sample is cryopreserved, cryo sectioned and then floated in a cryoprotectant solution on a surface of a glass slide or in a well and is viewed by light microscopy. The step of floating the tissue sample does not destroy said tissue sample for subsequent electron microscope viewing. The same tissue sample is then prepared by conventional ultrastructural processing for viewing by electron microscopy. The data from the light microscope and electron microscope images of selected sites of the same tissue sample can be compared and analyzed.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: April 29, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: John P. Petrali, Robert Kwai Kan, Tracey A. Hamilton, Susan B. Oglesby-Megee
  • Patent number: 6553252
    Abstract: An apparatus and method for predicting cognitive performance of an individual based on factors including sleep history and the time of day. The method facilitates the creation of predicted cognitive performance curves that allow an individual to set his/her sleep times to produce higher levels of cognitive performance. The method also facilitates the reconstruction of past cognitive performance levels based on sleep history.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: April 22, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas J. Balkin, Gregory L. Belenky, Stanley W. Hall, Gary H. Kamimori, Daniel P. Redmond, Helen C. Sing, Maria L. Thomas, David R. Thorne, Nancy Jo Wesensten
  • Patent number: 6541230
    Abstract: A reusable sponge or foam made of a polymer such as polyurethane is prepared containing a plurality of different enzymes or a cross-linked complex of the plurality of enzymes for detoxification of a diverse array of hazardous chemicals such as organophosphorus and/or organosulfur compounds. The plurality of enzymes include enzymes selected from acetylcholinesterase, butyrylcholinesterase, triesterase, pseudocholinesterase, choline oxidase, peroxidase, organophosphate hydrolase, phosphotriesterase, paraoxonase and laccase. A preferred mixture of enzymes contains organophosphate hydrolase and acetylcholinesterase or butyrylcholinesterase. The sponge or foam may additionally contain carbon, an enzyme reactivation compound and/or an indicator for measuring capacity for detoxification. The indicator can be fluorescent, chemiluminescent or visible chromogen or an electrode, and be encapsulated in a liposome or crushable packet.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: April 1, 2003
    Assignee: The United States of America as Represented by the Secretary of the Army
    Inventors: Richard K. Gordon, Bhupendra P. Doctor
  • Patent number: 6537557
    Abstract: The present invention provides vaccine compositions of attenuated dengue-4 virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against dengue-4 virus by administration of attenuated dengue-4 virus.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: March 25, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Kenneth H. Eckels, Joseph R. Putnak, Doria R. Dubois, Bruce L. Innis, Charles H. Hoke, David Vaughn
  • Patent number: 6533761
    Abstract: A device for securing a catheter with respect to a patient's mouth that preferably includes a balloon that can be inflated within the patient's mouth on the exterior of the catheter, a bite block, and a shield. The balloon preferably immobilizes the catheter with respect to the securing device when inflated while permitting relative movement of the catheter and the securing device when deflated. The balloon preferably also prevents inadvertent withdrawal of the securing device from the patient's mouth when inflated while permitting withdrawal when deflated. The invention preferably includes a method for using such a securing device.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: March 18, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Todd M. Bertoch, Ted F. Gingrich, Steven C. Walker, John M. Shepherd
  • Patent number: 6531487
    Abstract: Compounds, compositions and methods are provided for treating malaria parasites in vitro and in vivo by administering indolo[2,1-b]quinazoline-6,12-dione compounds of Formula I.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: March 11, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Kevin K. Pitzer, John P. Scovill, Dennis E. Kyle, Lucia Gerena
  • Patent number: 6530884
    Abstract: An apparatus and method for predicting cognitive performance of an individual based on factors including preferably sleep history, the time of day, and the individual's activities. The method facilitates the creation of predicted cognitive performance curves that allow an individual to set his/her sleep times to produce higher levels of cognitive performance. The method also facilitates the reconstruction of past cognitive performance levels based on sleep history.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: March 11, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas J. Balkin, Gregory L. Belenky, Stanley W. Hall, Gary H. Kamimori, Daniel P. Redmond, Helen C. Sing, Maria L. Thomas, David R. Thorne, Nancy Jo Wesensten
  • Patent number: 6528065
    Abstract: The present invention provides immunogenic compositions of attenuated dengue-1 virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against dengue-1 virus by administration of attenuated dengue-1 virus.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: March 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Kenneth H. Eckels, Joseph R. Putnak, Doria R. Dubois, Bruce L. Innis, Charles H. Hoke, David Vaughn
  • Patent number: 6527715
    Abstract: A system and a method for providing a determination of predicted cognitive performance of an individual preferably based the time of day and on factors including sleep history based on activity data from an actigraph and the individual's activities. The system and the method provide a numerical representation of the predicted cognitive performance. Both may be used to optimize the work schedule of the actigraph wearer to maximize the cognitive capacity during working hours.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: March 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas J. Balkin, Gregory L. Belenky, Stanley W. Hall, Gary H. Kamimori, Daniel P. Redmond, Helen C. Sing, Maria L. Thomas, David R. Thorne, Nancy Jo Wesensten
  • Patent number: 6528097
    Abstract: A controlled release microcapsule pharmaceutical formulation for burst-free, sustained, programmable release of a non-steroidal, antiinflammatory drug over a duration from 24 hours to 2 months, comprising: a non-steroidal, antiinflammatory drug and a blend of biocompatible, biodegradable poly (lactide/glycolide).
    Type: Grant
    Filed: November 20, 2000
    Date of Patent: March 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: William M. Vaughn, John E. Van Hamont, Jean A. Setterstrom
  • Patent number: 6517842
    Abstract: The invention here relates to recombinant DNA constructs which comprise a Venezuelan equine encephalitis replicon vector and at least one DNA fragment encoding a protective antigen from the Marburg virus. The DNA constructs are useful for inducing an immune response which is protective against infection with Marburg virus in nonhuman primates.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: February 11, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Michael C. Hevey, Diane L. Negley, Peter Pushko, Jonathan F. Smith, Alan L. Schmaljohn
  • Patent number: 6514501
    Abstract: A recombinant protein encompassing the complete envelope glycoprotein and a portion of the carboxy-terminus of the membrane/premembrane protein of dengue 2 virus was expressed in baculovirus as a protein particle. The recombinant protein particle was purified and found to provide protection against lethal challenge with dengue 2 virus in mice.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: February 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Eileen P. Kelly, Alan D. King
  • Patent number: 6514208
    Abstract: This invention relates to estimating the amount of blood flowing to the tissues of the kidney. More particularly, the invention is related to analyzing obtained power Doppler ultrasound images taken of the kidney and even more specifically of the kidney cortex tissue to produce a numerical value that correlates to the blood flow.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: February 4, 2003
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Leopoldo C. Cancio, Natalia P. Matylevitch, Toshiyuki Kuwa